Nitroglycerin Transdermal Patches Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 180 Category: Pharma & Healthcare Report Code : HC117178
Nitroglycerin Transdermal Patches Market by Type (0.2 Mg/Patch, 0.4 Mg/Patch, 0.6 Mg/Patch, 0.8 Mg/Patch) Application (Coronary Heart Disease, Angina, Other) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The nitroglycerin transdermal patches market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Nitroglycerin transdermal patches are utilized to anticipate episodes of angina in individuals who have coronary artery disease. Nitroglycerin transdermal patches must be utilized to forestall assaults of angina, they can't be utilized to treat an assault of angina once it has started. Nitroglycerin is in a class of drugs called vasodilators. It works by relaxing the blood vessels with the goal that the heart doesn't have to fill in as hard and along these lines doesn't require as a lot of oxygen.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global nitroglycerin transdermal patches market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Merck Sharp & Dohme Corp
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Nitroglycerin Transdermal Patches Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o 0.2 Mg/Patch
o 0.4 Mg/Patch
o 0.6 Mg/Patch
o 0.8 Mg/Patch
· Nitroglycerin Transdermal Patches Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Coronary Heart Disease
o Angina
o Other
· Nitroglycerin Transdermal Patches Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Merck Sharp & Dohme Corp
· Nitroglycerin Transdermal Patches Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Nitroglycerin Transdermal Patches Market, By Country
o U.S. Nitroglycerin Transdermal Patches Market
o Canada Nitroglycerin Transdermal Patches Market
o Mexico Nitroglycerin Transdermal Patches Market
o Europe
§ Europe Nitroglycerin Transdermal Patches Market, By Country
o Germany Nitroglycerin Transdermal Patches Market
o UK Nitroglycerin Transdermal Patches Market
o France Nitroglycerin Transdermal Patches Market
o Russia Nitroglycerin Transdermal Patches Market
o Italy Nitroglycerin Transdermal Patches Market
o Rest of Europe Nitroglycerin Transdermal Patches Market
o Asia-Pacific
§ Asia-Pacific Nitroglycerin Transdermal Patches Market, By Country
o China Nitroglycerin Transdermal Patches Market
o Japan Nitroglycerin Transdermal Patches Market
o South Korea Nitroglycerin Transdermal Patches Market
o India Nitroglycerin Transdermal Patches Market
o Southeast Asia Nitroglycerin Transdermal Patches Market
o Rest of Asia-Pacific Nitroglycerin Transdermal Patches Market
o South America
§ South America Nitroglycerin Transdermal Patches Market
o Brazil Nitroglycerin Transdermal Patches Market
o Argentina Nitroglycerin Transdermal Patches Market
o Columbia Nitroglycerin Transdermal Patches Market
o Rest of South America Nitroglycerin Transdermal Patches Market
o Middle East and Africa
§ Middle East and Africa Nitroglycerin Transdermal Patches Market
o Saudi Arabia Nitroglycerin Transdermal Patches Market
o UAE Nitroglycerin Transdermal Patches Market
o Egypt Nitroglycerin Transdermal Patches Market
o Nigeria Nitroglycerin Transdermal Patches Market
o South Africa Nitroglycerin Transdermal Patches Market
o Rest of MEA Nitroglycerin Transdermal Patches Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Nitroglycerin Transdermal Patches Market, By Type
5.1. Introduction
5.2. Global Nitroglycerin Transdermal Patches Revenue and Market Share by Type (2017-2027)
5.2.1. Global Nitroglycerin Transdermal Patches Revenue and Revenue Share by Type (2017-2027)
5.3. 0.2 Mg/Patch
5.3.1. Global 0.2 Mg/Patch Revenue and Growth Rate (2017-2027)
5.4. 0.4 Mg/Patch
5.4.1. Global 0.4 Mg/Patch Revenue and Growth Rate (2017-2027)
5.5. 0.6 Mg/Patch
5.5.1. Global 0.6 Mg/Patch Revenue and Growth Rate (2017-2027)
5.6. 0.8 Mg/Patch
5.6.1. Global 0.8 Mg/Patch Revenue and Growth Rate (2017-2027)
6. Nitroglycerin Transdermal Patches Market, By Application
6.1. Introduction
6.2. Global Nitroglycerin Transdermal Patches Revenue and Market Share by Application (2017-2027)
6.2.1. Global Nitroglycerin Transdermal Patches Revenue and Revenue Share by Application (2017-2027)
6.3. Coronary Heart Disease
6.3.1. Global Coronary Heart Disease Revenue and Growth Rate (2017-2027)
6.4. Angina
6.4.1. Global Angina Revenue and Growth Rate (2017-2027)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2027)
7. Nitroglycerin Transdermal Patches Market, By Region
7.1. Introduction
7.2. Global Nitroglycerin Transdermal Patches Revenue and Market Share by Regions
7.2.1. Global Nitroglycerin Transdermal Patches Revenue by Regions (2017-2027)
7.3. North America Nitroglycerin Transdermal Patches by Countries
7.3.1. North America Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2027)
7.3.2. North America Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Nitroglycerin Transdermal Patches by Countries
7.4.1. Europe Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2027)
7.4.2. Europe Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Nitroglycerin Transdermal Patches by Countries
7.5.1. Asia-Pacific Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Nitroglycerin Transdermal Patches by Countries
7.6.1. South America Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2027)
7.6.2. South America Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Nitroglycerin Transdermal Patches by Countries
7.7.1. Middle East and Africa Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Merck Sharp & Dohme Corp
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
9. Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.1. Global Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Nitroglycerin Transdermal Patches Market Forecast by Regions (2017-2027)
9.2.1. North America Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.1.1. United States Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.1.2. Canada Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.1.3. Mexico Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2. Europe Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2.1. Germany Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2.2. France Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2.3. UK Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2.4. Russia Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2.5. Italy Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3. Asia-Pacific Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3.1. China Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3.2. Japan Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3.3. Korea Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3.4. India Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.4. South America Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.4.1. Brazil Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.4.2. Argentina Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.4.3. Columbia Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.4.4. Rest of South America Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5. Middle East and Africa Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.3. Egypt Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.4. Nigeria Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.5. South Africa Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.6. Turkey Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Nitroglycerin Transdermal Patches Market Forecast (2017-2027)
9.3. Nitroglycerin Transdermal Patches Market Forecast by Type (2017-2027)
9.3.1. Nitroglycerin Transdermal Patches Forecast by Type (2017-2027)
9.3.2. Nitroglycerin Transdermal Patches Market Share Forecast by Type (2017-2027)
9.4. Nitroglycerin Transdermal Patches Market Forecast by Application (2017-2027)
9.4.1. Nitroglycerin Transdermal Patches Forecast by Application (2017-2027)
9.4.2. Nitroglycerin Transdermal Patches Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Nitroglycerin Transdermal Patches Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Nitroglycerin Transdermal Patches Revenue and Revenue Share by Type (2017-2018)
Figure Global 0.2 Mg/Patch Revenue and Growth Rate (2017-2018)
Figure Global 0.4 Mg/Patch Revenue and Growth Rate (2017-2018)
Figure Global 0.6 Mg/Patch Revenue and Growth Rate (2017-2018)
Figure Global 0.8 Mg/Patch Revenue and Growth Rate (2017-2018)
Table Global Nitroglycerin Transdermal Patches Revenue and Revenue Share by Application (2017-2018)
Figure Global Coronary Heart Disease Revenue and Growth Rate (2017-2018)
Figure Global Angina Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Nitroglycerin Transdermal Patches Revenue by Regions (2017-2018)
Figure North America Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure North America Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2018)
Figure North America Nitroglycerin Transdermal Patches by Countries (2017-2018)
Figure North America Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2018)
Figure United States Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure United States Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Canada Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Mexico Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Europe Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2018)
Figure Europe Nitroglycerin Transdermal Patches by Countries (2017-2018)
Figure Europe Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2018)
Figure Germany Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Germany Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure France Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure UK Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Russia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Italy Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Rest of Europe Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Asia-Pacific Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Nitroglycerin Transdermal Patches by Countries (2017-2018)
Figure Asia-Pacific Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2018)
Figure China Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure China Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Japan Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Korea Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure India Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Southeast Asia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure South America Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2018)
Figure South America Nitroglycerin Transdermal Patches by Countries (2017-2018)
Figure South America Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Brazil Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Argentina Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Columbia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Rest of South America Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Middle East and Africa Nitroglycerin Transdermal Patches Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Nitroglycerin Transdermal Patches by Countries (2017-2018)
Figure Middle East and Africa Nitroglycerin Transdermal Patches Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Saudi Arabia Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure United Arab Emirates Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Egypt Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Nigeria Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure South Africa Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Turkey Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Nitroglycerin Transdermal Patches Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2017-2018)
Table Merck Sharp & Dohme Corp Nitroglycerin Transdermal Patches Financial Overview
Figure Global Nitroglycerin Transdermal Patches Revenue (Millions USD) and Growth Rate (2018-2025)
Table Nitroglycerin Transdermal Patches Market Forecast by Regions (2018-2025)
Figure North America Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure United States Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Canada Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Mexico Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Europe Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Germany Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure France Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure UK Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Russia Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Italy Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Rest of Europe Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Asia-Pacific Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure China Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Japan Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Korea Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure India Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Southeast Asia Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure South America Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Brazil Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Argentina Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Columbia Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Rest of South America Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Middle East and Africa Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Saudi Arabia Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure United Arab Emirates Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Egypt Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Nigeria Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure South Africa Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Turkey Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Nitroglycerin Transdermal Patches Market Forecast (2018-2025)
Figure Global Nitroglycerin Transdermal Patches Forecast by Type (2018-2025)
Figure Global Nitroglycerin Transdermal Patches Market Share Forecast by Type (2018-2025)
Figure Global Nitroglycerin Transdermal Patches Forecast by Type (2018-2025)
Figure Global Nitroglycerin Transdermal Patches Forecast by Application (2018-2025)
Figure Global Nitroglycerin Transdermal Patches Market Share Forecast by Application (2018-2025)
Figure Global Nitroglycerin Transdermal Patches Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|